Results 311 to 320 of about 683,288 (403)

The Role of miRNAs as Early Biomarkers in Obesity-Related Glomerulopathy: Implications for Early Detection and Treatment. [PDF]

Biomedicines
Navarro-Díaz M, López-Martínez M.
europepmc   +1 more source

Age and outcomes in people with type 2 diabetes admitted to hospital with COVID‐19: A cohort study

Diabetic Medicine, Volume 42, Issue 4, April 2025.
M. Ni'Man, Y. Ruan, J. Davies, S. Harris, D. Nagi, P. Narendran, B. C. T. Field, I. Idris, D. Patel, R. Rea, R. E. J. Ryder, S. H. Wild, K. A. Várnai, E. G. Wilmot, K. Khunti   +14 more
wiley   +1 more source

Developments in albuminuria testing: A key biomarker for detection, prognosis and surveillance of kidney and cardiovascular disease—A practical update for clinicians

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Albuminuria, the abnormal presence of albumin in urine, is a key marker of kidney damage and a strong predictor of kidney and cardiovascular outcomes. Its clinical significance has evolved from early historical observations to its current role in chronic kidney disease (CKD) detection, risk stratification and treatment monitoring.
Jelle M. Beernink, Dominique van Mil, Gozewijn D. Laverman, Hiddo J. L. Heerspink, Ron T. Gansevoort   +4 more
wiley   +1 more source

Protective effect of <i>Astragalus</i> polysaccharide on diabetic nephropathy: A systematic review and meta‑analysis reveals the efficacy and potential mechanisms. [PDF]

Biomed Rep
He Y, Zhao WJ, Yang ZC, Qin MM, Wang Q, Lin S.   +5 more
europepmc   +1 more source

The interplay between heart failure and chronic kidney disease

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Chronic kidney disease (CKD) and heart failure (HF) are two globally prevalent, independent, long‐term conditions, which often coexist in an individual and display a bidirectional yet interconnected relationship. The presence of CKD often leads to the development of HF and vice versa, which propagates the worsening of each disease, reflecting ...
Anuradha Lala, Adeera Levin, Kamlesh Khunti   +2 more
wiley   +1 more source

Antineutrophil Cytoplasmic Antibodies-Associated Glomerulonephritis in Diabetic Kidney Disease. [PDF]

Cureus
Landeros GA, Amador LF, Flores MA, Sánchez MD, Juárez JO, Abraham SM, Jiménez OA, Vázquez JD.   +7 more
europepmc   +1 more source

A review of the safety of sodium‐glucose co‐transporter‐2 inhibitors

Diabetes, Obesity and Metabolism, EarlyView.
Abstract The development of sodium‐glucose co‐transporter‐2 (SGLT2) inhibitors represents a major turning point in the effort to preserve kidney function and prevent cardiovascular events and heart failure hospitalisations in those at high risk. These agents have now transcended their original glucose‐lowering indication and provide a range of clinical
Daniel Vincent O'Hara, Meg J. Jardine
wiley   +1 more source

Incidence and influencing factors for hypoglycemia in maintenance hemodialysis patients with diabetic kidney disease: a meta-analysis. [PDF]

Am J Transl Res
Jiang F, Wu B, Qin Z, Xie Y, Yi N, Chen W, Xu H.   +6 more
europepmc   +1 more source

Transitional changes in medication‐initiator cohort profiles in persons with chronic kidney disease and type 2 diabetes—A hospital‐based cohort study in Japan

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Aims To describe temporal changes in the characteristics of medication‐initiator cohorts in persons with chronic kidney disease (CKD) and type 2 diabetes (T2D). Materials and Methods Adults with CKD and T2D initiating sodium‐glucose cotransporter‐2 inhibitors (SGLT‐2i) or glucagon‐like peptide‐1 receptor agonists (GLP‐1RA) were identified in ...
Yuichiro Yano, Suguru Okami, Hiroshi Kanegae, Nikolaus G. Oberprieler, Catherine Johannes, Satoshi Yamashita, Kanae Yoshikawa‐Ryan, Csaba P. Kovesdy, David Vizcaya, Naoki Kashihara   +9 more
wiley   +1 more source

Effects of Occupational Noise Exposure on Disease Control and Psychological Status in Patients with Diabetic Nephropathy.

Noise Health
Zhou X, Guo T, Lin L.
europepmc   +1 more source